Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-22 · accession 0001415889-22-011763 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-23 | 2022-11-22 | TBPH | O'Connor Donal | Dir | D - Sale to Iss | $10.50 | -10.0K | 43.9K | -19% | -$105.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-11-22 | D | D | 10,000 | $10.50 | 43,886 | D | — | — | (F1) Represents ordinary shares tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's Dutch auction tender offer for up to $95 million of its ordinary shares. |